Title:
OPHTHALMIC COMPOSITION FOR SUPPRESSING DEGRADATION OF SOFT CONTACT LENS
Document Type and Number:
WIPO Patent Application WO/2020/090895
Kind Code:
A1
Abstract:
The present invention provides: an ophthalmic composition which has an effect of suppressing the degradation of a soft contact lens, the ophthalmic composition containing a boric acid or a salt thereof and an epinastine or a salt thereof; and a pollen rupture inhibitor containing a specific concentration of a boric acid or a salt thereof and an epinastine or a salt thereof.
Inventors:
MORIMOTO TAKASHI (JP)
INAGAKI KOJI (JP)
OGAWA TOSHIHIRO (JP)
MOMOKAWA YUSUKE (JP)
INAGAKI KOJI (JP)
OGAWA TOSHIHIRO (JP)
MOMOKAWA YUSUKE (JP)
Application Number:
PCT/JP2019/042590
Publication Date:
May 07, 2020
Filing Date:
October 30, 2019
Export Citation:
Assignee:
SANTEN PHARMACEUTICAL CO LTD (JP)
International Classes:
A61K31/55; A61K9/08; A61K47/02; A61K47/18; A61P27/02; A61P27/14; G02C7/04
Domestic Patent References:
| WO2015152155A1 | 2015-10-08 | |||
| WO2007088783A1 | 2007-08-09 |
Foreign References:
| JP2018102535A | 2018-07-05 | |||
| JP2018102534A | 2018-07-05 |
Other References:
SUGIO, YOSHIHIRO ET AL.: "The Allergy in Practice", vol. 36, 2016, article "Pharmacological action and clinical result of epinastine hydrochloride ophthalmic solution", pages: 43 - 51
"Antiallergic ophthalmic agent, Alesion (registered trademark) ophthalmic solution 0.05%, ' Composition and Properties', 'Usage and Dosage", 2017, pages 1 - 4
ALLERGOLOGY & IMMUNOLOGY, vol. 23, no. 10, 2016, pages 64 - 71
"Antiallergic ophthalmic agent, Alesion (registered trademark) ophthalmic solution 0.05%, ' Composition and Properties', 'Usage and Dosage", 2017, pages 1 - 4
ALLERGOLOGY & IMMUNOLOGY, vol. 23, no. 10, 2016, pages 64 - 71
Attorney, Agent or Firm:
YAMAO, Norihito et al. (JP)
Download PDF:
Previous Patent: LASER PROCESSING DEVICE AND LASER PROCESSING METHOD
Next Patent: LASER MACHINING DEVICE
Next Patent: LASER MACHINING DEVICE